FDA Approved: KRYSTEXXA — Original Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

FDA approves KRYSTEXXA (pegloticase) under the original Biologics License Application for adults with chronic gout refractory to conventional therapy. This prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• KRYSTEXXA (pegloticase)

Snippet

ORIG AP for KRYSTEXXA (PEGLOTICASE)